Good News for Humankind

Your daily spark of possibility

The world is changing — for the better, and in real, indisputable ways. Climate breakthroughs. Justice wins. Scientific discoveries. From people you’ve never heard of. In places you wouldn’t expect.

Every weekday, I send a piece of good news from around the world — not to sugarcoat reality, but to remind you that change is possible.

Every weekday morning at 7am. Or sign up for the weekly digest.

What Readers Are Saying

It restores my faith that homo sapiens sapiens, even if not in everything and always, deserves the name it has given itself.

Eszter

Peter is all passion. He’s spent years working toward the greater good by helping his readership and community becoming the best version of themselves. His thoughtfully curated positive news stories stem from his genuine and effortless capacity to empathize. You’re an inspiration, Peter. Thank you!

Athos Cakiades Company Name

Good News daily restores my faith in humanity and in Universal Source; I’ve shared this newsletter with family and friends and we love it! Hurray for Peter’s inspiration and generosity! So grateful.

Eve Thompson Company Name

I forward this to friends who need a remedy for despair.

Alice PrestonCompany Name

Good News for Humankind has been a crack of light in my inbox for years
because it provides a some counter balance to the dystopian info-tsunami
that passes for news from other sources.

Tim TaylorCompany Name

The Latest Good News

Search

Topic

Country

Actor

Artwork of path into mind, for article on Colorado psychedelic decriminalization

2022 C.E. November 10

Colorado voters pass historic psychedelic decriminalization act

Colorado's Natural Medicine Health Act goes further than any previous U.S. state psychedelic law, removing criminal penalties for personal use of psilocybin, DMT, ibogaine, and mescaline — and building a licensed therapy clinic system alongside it. The FDA has already granted psilocybin "breakthrough therapy" status for treatment-resistant depression, giving this reform unusual clinical credibility. Colorado helped pioneer cannabis legalization in 2012, and advocates are watching to see whether psychedelic reform follows a similar path...

Blood cells under microscope, for article on smart insulin, for article on lab-grown blood cells

2022 C.E. November 8

First human patients receive transfusions of lab-grown blood cells

Lab-grown blood cells have reached a genuine turning point: manufactured red blood cells grown from stem cells have been safely transfused into human patients for the first time. What makes these cells special is their freshness — unlike donated blood, every lab-grown cell is the same age, meaning they should last closer to the full 120-day lifespan and reduce repeat transfusions. Early participants completed the process with no adverse effects. For millions worldwide living...

Cancer cells, for article on radioactive implant pancreatic cancer

2022 C.E. October 31

Radioactive implant wipes tumors in unprecedented pre-clinical success

Pancreatic cancer is one of the hardest diseases medicine has ever faced, and a new implant from Duke University is producing results that researchers say have no match in the existing scientific record. The device injects a radioactive gel directly into tumors, trapping iodine-131 so it radiates from the inside out before safely dissolving into harmless amino acids. Combined with chemotherapy, it eliminated tumors in the majority of mouse models tested. Human trials remain...

Cannabis being weighed, for article on legal cannabis dispensary, for article on Germany cannabis legalization

2022 C.E. October 26

Germany to become second E.U. nation to legalize recreational cannabis

Recreational cannabis legalization in Germany would mark a significant shift for Europe's largest economy — moving the country away from a prohibition model that its own health minister says has shown no clear results. The proposal would allow licensed shops and pharmacies to sell cannabis to adults, with age-based limits on potency designed to protect younger users. Because Germany sits at the heart of the E.U., its approach could reshape how other member states...

Measuring Psilocybin Magic Mushroom Micro Doses in Laboratory for A Scientific Experiment, for article on psilocybin therapy

2022 C.E. October 24

The world’s first Phase 3 psilocybin clinical trial is about to commence

Psilocybin therapy is making history: Compass Pathways will launch the world's first Phase 3 trial for treatment-resistant depression by the end of 2022, enrolling nearly 1,000 participants across two pivotal studies. This is the threshold every promising drug must cross to become an approved medicine, and no psychedelic compound has crossed it before. For the roughly 100 million people worldwide whose depression doesn't respond to standard treatments, the stakes are real — current options...

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161

Enjoying these stories? Get one delivered to your inbox every weekday morning — free.

Go to good news archives for specific countries, institutions, topics, etc.